Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

380 ARTÍCULOS , VIENDO DEL 256 AL 270

Soluble TREM2 changes during the clinical course of Alzheimer's disease: A meta-analysis

Liu D, Cao B, Zhao Y, Huang H, McIntyre RS, Rosenblat JD, Zhou H.

Neurosci Lett. 2018 Nov 1;686:10-16. doi: 10.1016/j.neulet.2018.08.038. Epub 2018 Aug 29.

Resveratrol's Potential in the Adjunctive Management of Cardiovascular Disease, Obesity, Diabetes, Alzheimer Disease, and Cancer

Kulashekar M, Stom SM, Peuler JD.

J Am Osteopath Assoc. 2018 Sep 1;118(9):596-605. doi: 10.7556/jaoa.2018.133.

Neuroprotective Activity of Sitagliptin via Reduction of Neuroinflammation beyond the Incretin Effect: Focus on Alzheimer's Disease

Wiciński M, Wódkiewicz E, Słupski M, Walczak M, Socha M, Malinowski B, Pawlak-Osińska K.

Biomed Res Int. 2018 Aug 16;2018:6091014. doi: 10.1155/2018/6091014. eCollection 2018.

Alzheimer's Disease: A Review from the Pathophysiology to Diagnosis, New Perspectives for Pharmacological Treatment

Dos Santos Picanco LC, Ozela PF, de Fatima de Brito Brito M, Pinheiro AA, Padilha EC, Braga FS, de Paula da Silva CHT, Dos Santos CBR, Rosa JMC, da Silva Hage-Melim LI.

Curr Med Chem. 2018;25(26):3141-3159. doi: 10.2174/0929867323666161213101126.

A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease

O'Bryant SE, Zhang F, Johnson LA, Hall J, Edwards M, Grammas P, Oh E, Lyketsos CG, Rissman RA.

J Alzheimers Dis. 2018;66(1):97-104. doi: 10.3233/JAD-180619.

Heat Shock Proteins in Alzheimer's Disease: Role and Targeting

Campanella C, Pace A, Caruso Bavisotto C, Marzullo P, Marino Gammazza A, Buscemi S, Palumbo Piccionello A.

Int J Mol Sci. 2018 Sep 1;19(9):2603. doi: 10.3390/ijms19092603.

The efficacy and safety of memantine for the treatment of Alzheimer's disease

Matsunaga S, Kishi T, Nomura I, Sakuma K, Okuya M, Ikuta T, Iwata N.

Expert Opin Drug Saf. 2018 Oct;17(10):1053-1061. doi: 10.1080/14740338.2018.1524870. Epub 2018 Sep 26.

Rollercoaster ride of kynurenines: steering the wheel towards neuroprotection in Alzheimer's disease

Sharma R, Razdan K, Bansal Y, Kuhad A.

Expert Opin Ther Targets. 2018 Oct;22(10):849-867. doi: 10.1080/14728222.2018.1524877. Epub 2018 Sep 25.

The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease

Neumann U, Ufer M, Jacobson LH, Rouzade-Dominguez ML, Huledal G, Kolly C, Lüönd RM, Machauer R, Veenstra SJ, Hurth K, Rueeger H, Tintelnot-Blomley M, Staufenbiel M, Shimshek DR, Perrot L, Frieauff W, Dubost V, Schiller H, Vogg B, Beltz K, Avrameas A, Kretz S, Pezous N, Rondeau JM, Beckmann N, Hartmann A, Vormfelde S, David OJ, Galli B, Ramos R, Graf A, Lopez Lopez C.

EMBO Mol Med. 2018 Nov;10(11):e9316. doi: 10.15252/emmm.201809316.

Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)

Salloway S, Honigberg LA, Cho W, Ward M, Friesenhahn M, Brunstein F, Quartino A, Clayton D, Mortensen D, Bittner T, Ho C, Rabe C, Schauer SP, Wildsmith KR, Fuji RN, Suliman S, Reiman EM, Chen K, Paul R.

Alzheimers Res Ther. 2018 Sep 19;10(1):96. doi: 10.1186/s13195-018-0424-5.

Physical activity can improve cognition in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials

Du Z, Li Y, Li J, Zhou C, Li F, Yang X.

Clin Interv Aging. 2018 Sep 4;13:1593-1603. doi: 10.2147/CIA.S169565. eCollection 2018.

Chinese Medicine for Alzheimer's Disease: A Meta-Analysis of Randomized Controlled Trials

Ma HK, Liu Y, Li B, Zhang Y, Sun LJ, Xu FQ.

Chin J Integr Med. 2018 Dec;24(12):938-943. doi: 10.1007/s11655-018-2567-4. Epub 2018 Sep 22.

Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease

Li Q, He S, Chen Y, Feng F, Qu W, Sun H.

Eur J Med Chem. 2018 Oct 5;158:463-477. doi: 10.1016/j.ejmech.2018.09.031. Epub 2018 Sep 13.

DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective

Pathak A, Rohilla A, Gupta T, Akhtar MJ, Haider MR, Sharma K, Haider K, Yar MS.

Eur J Med Chem. 2018 Oct 5;158:559-592. doi: 10.1016/j.ejmech.2018.08.093. Epub 2018 Sep 11.

An evaluation of memantine ER + donepezil for the treatment of Alzheimer's disease

Calhoun A, King C, Khoury R, Grossberg GT.

Expert Opin Pharmacother. 2018 Oct;19(15):1711-1717. doi: 10.1080/14656566.2018.1519022. Epub 2018 Sep 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias